The role of topotecan in the treatment of advanced cervical cancer
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 90 (3) , S16-S21
- https://doi.org/10.1016/s0090-8258(03)00465-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Update on the Treatment of Cervical and Uterine Carcinoma: Focus on TopotecanThe Oncologist, 2002
- The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospectsAnti-Cancer Drugs, 2001
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixJournal of Clinical Oncology, 2000
- Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer: M Morris M, PJ Eifel PJ, J Lu J, PW Grigsby PW, C Levenback C, RE Srevens RE, M Rotman, DM Gershenson, DG Mutch N Engl J Med 1999; 340: 1137-43Cancer/Radiothérapie, 1999
- Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group StudyJournal of Clinical Oncology, 1999
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Cancer of the Uterine CervixNew England Journal of Medicine, 1996